XML 167 R59.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule of the Original and Restated Statement of Cash Flows (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 28, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:                      
Net loss   $ (2,058,000) $ (3,589,000) $ (2,109,000) $ (13,840,000) $ (9,601,000) $ (7,843,000) $ (7,755,000) $ (31,284,000) $ (33,780,000) [1] $ (30,451,000) [2]
Adjustments to reconcile net loss to net cash used in operating activities:                      
Depreciation and amortization               31,000 19,000 28,000 25,000
Business combination cost [3]                    
Cash held in trust account                   [4] [5]
Stock-based compensation expense               447,000 1,446,000 1,475,000 [6] 1,865,000 [7]
Stock warrant expense                   9,207,000 [8] 8,073,000 [9]
Board of director warrant expense                   (1,198,000) [9]
Change in fair value of warrant liabilities [10]                   (129,000)  
Change in fair value of PIPE Notes [11]                   269,000  
Change in fair value of convertible promissory notes               17,872,000 17,517,000 [12] 14,616,000 [13]
Non-cash interest               96,000 11,000 [14]
Change in operating assets and liabilities:                      
Accounts receivable               89,000 (86,000) (133,000) 73,000
Prepaid expenses and other current assets               15,000 14,000 (43,000) [3],[4] (59,000) [5]
Accounts payable & accrued expenses               1,232,000 340,000 717,000 [3],[4],[15] 415,000 [5],[16]
Deferred revenues               174,000 228,000 70,000 (458,000)
Amount due to related party                   [5]
Excise tax liability [3],[4]                    
Extension loan                   [3],[4] [5]
Franchise tax payable                   [3],[4] [5]
Income tax payable                   [3],[4] [5]
Working capital loan                   [3],[4] [5]
Net cash used in operating activities               (4,956,000) (3,066,000) (4,791,000) (4,703,000)
Cash flows from investing activities:                      
Purchases of property and equipment               (16,000) (28,000) (44,000) (58,000)
Net cash used in investing activities               (2,347,000) (28,000) (44,000) (58,000)
Cash flows from financing activities:                      
Payments of Canada Emergency Business Loan Act                  
Proceeds from issuance of shareholder loans               2,000,000 704,000 454,000 [14]
Proceeds from issuance of PIPE notes                   1,500,000 [11]
Common stock subject to redemption                   [3] [5]
Deferred underwriting fee [3]                    
Warrant liability                   [3] [5]
Additional paid-in capital                   [3] [5]
Retained earnings adjustment                   [3] [5]
Proceeds from issuance of convertible notes $ 4,500,000             3,875,000 4,175,000 [12] 5,140,000 [13]
Proceeds from exercise of stock options                   8,000
Proceeds from issuance of Series A-2 preferred stock [3]                   16,000  
Business Combination Costs               (1,160,000) (1,534,000) [3] (815,000) [5]
Net cash provided by financing activities               9,190,000 3,435,000 4,611,000 4,333,000
Net decrease in cash and cash equivalents               1,887,000 341,000 (224,000) (428,000)
Cash and cash equivalents at beginning year       47,000     271,000 47,000 271,000 271,000 699,000
Cash and cash equivalents at end of year   $ 1,934,000     $ 612,000     1,934,000 612,000 47,000 271,000
Supplemental disclosures of non-cash investing and financing activities:                      
Common shares issued to preferred shareholders [3]                   17,659,000  
Common shares related to convertible promissory notes                   47,935,000 [3]
Common shares issued to Data Knights shareholders                   (11,937,000) [3]
Board of director warrant expense                   1,198,000 [9]
Previously Reported [Member]                      
Cash flows from operating activities:                      
Net loss                   (23,206,000) [1] (6,230,000) [2]
Adjustments to reconcile net loss to net cash used in operating activities:                      
Depreciation and amortization                   28,000 25,000
Business combination cost [3]                   900,000  
Cash held in trust account                   29,029,000 [4] 88,292,000 [5]
Stock-based compensation expense                   [6] 1,600,000 [7]
Stock warrant expense                   [8] [9]
Board of director warrant expense                   [9]
Change in fair value of warrant liabilities [10]                    
Change in fair value of PIPE Notes [11]                    
Change in fair value of convertible promissory notes                   [12] [13]
Non-cash interest [14]                    
Change in operating assets and liabilities:                      
Accounts receivable                   (133,000) 73,000
Prepaid expenses and other current assets                   (65,000) [3],[4] (876,000) [5]
Accounts payable & accrued expenses                   1,372,000 [3],[4],[15] 1,929,000 [5],[16]
Deferred revenues                   70,000 (458,000)
Amount due to related party                   12,000 [5]
Excise tax liability [3],[4]                   113,000  
Extension loan                   446 [3],[4] 2,546,000 [5]
Franchise tax payable                   (70,000) [3],[4] (94,000) [5]
Income tax payable                   (95,000) [3],[4] 215,000 [5]
Working capital loan                   (168,000) [3],[4] 207,000 [5]
Net cash used in operating activities                   8,221,000 87,241,000
Cash flows from investing activities:                      
Purchases of property and equipment                   (44,000) (58,000)
Net cash used in investing activities                   (44,000) (58,000)
Cash flows from financing activities:                      
Payments of Canada Emergency Business Loan Act                   (3,000)
Proceeds from issuance of shareholder loans [14]                   465,000  
Proceeds from issuance of PIPE notes [11]                   1,550,000  
Common stock subject to redemption                   (28,750,000) [3] (88,550,000) [5]
Deferred underwriting fee [3]                   (500,000)  
Warrant liability                   (338,000) [3] (4,489,000) [5]
Additional paid-in capital                   18,189,000 [3] 2,826,000 [5]
Retained earnings adjustment                   11,633,000 [3] (3,360,000) [5]
Proceeds from issuance of convertible notes                   (10,681,000) [12] 5,543,000 [13]
Proceeds from exercise of stock options                  
Proceeds from issuance of Series A-2 preferred stock [3]                    
Business Combination Costs                   [3] [5]
Net cash provided by financing activities                   (8,432,000) (88,033,000)
Net decrease in cash and cash equivalents                   (255,000) (850,000)
Cash and cash equivalents at beginning year       47,000     302,000 47,000 302,000 302,000 1,152,000
Cash and cash equivalents at end of year                   47,000 302,000
Supplemental disclosures of non-cash investing and financing activities:                      
Common shares issued to preferred shareholders [3]                    
Common shares related to convertible promissory notes [3]                    
Common shares issued to Data Knights shareholders [3]                    
Board of director warrant expense                   [9]
Revision of Prior Period, Reclassification, Adjustment [Member]                      
Cash flows from operating activities:                      
Net loss                   (10,574,000) [1],[17] (24,221,000) [2],[18]
Adjustments to reconcile net loss to net cash used in operating activities:                      
Depreciation and amortization                  
Business combination cost [3]                   (900,000)  
Cash held in trust account                   (29,029,000) [4] (88,292,000) [5]
Stock-based compensation expense                   1,475,000 [6] 265,000 [7]
Stock warrant expense                   9,207,000 [8] 8,073,000 [9]
Board of director warrant expense                   (1,198,000) [9]
Change in fair value of warrant liabilities [10]                   (129,000)  
Change in fair value of PIPE Notes [11]                   269,000  
Change in fair value of convertible promissory notes                   17,517,000 [12] 14,616,000 [13]
Non-cash interest [14]                   11,000  
Change in operating assets and liabilities:                      
Accounts receivable                  
Prepaid expenses and other current assets                   22,000 [3],[4] 817,000 [5]
Accounts payable & accrued expenses                   (655,000) [3],[4],[15] (1,514,000) [5],[16]
Deferred revenues                  
Amount due to related party                   (12,000) [5]
Excise tax liability [3],[4]                   (113,000)  
Extension loan                   (446) [3],[4] (2,546,000) [5]
Franchise tax payable                   70,000 [3],[4] 94,000 [5]
Income tax payable                   95,000 [3],[4] (215,000) [5]
Working capital loan                   168,000 [3],[4] (207,000) [5]
Net cash used in operating activities                   (13,012,000) (91,944,000)
Cash flows from investing activities:                      
Purchases of property and equipment                  
Net cash used in investing activities                  
Cash flows from financing activities:                      
Payments of Canada Emergency Business Loan Act                   3,000
Proceeds from issuance of shareholder loans [14]                   (11,000)  
Proceeds from issuance of PIPE notes [11]                   (50,000)  
Common stock subject to redemption                   28,750,000 [3] 88,550,000 [5]
Deferred underwriting fee [3]                   500,000  
Warrant liability                   338,000 [3] 4,489,000 [5]
Additional paid-in capital                   (18,189,000) [3] (2,826,000) [5]
Retained earnings adjustment                   (11,633,000) [3] 3,360,000 [5]
Proceeds from issuance of convertible notes                   14,856,000 [12] (403,000) [13]
Proceeds from exercise of stock options                   8,000
Proceeds from issuance of Series A-2 preferred stock [3]                   16,000  
Business Combination Costs                   (1,534,000) [3] (815,000) [5]
Net cash provided by financing activities                   13,043,000 92,366,000
Net decrease in cash and cash equivalents                   31,000 422,000
Cash and cash equivalents at beginning year           $ (31,000) $ (31,000) (31,000) (453,000)
Cash and cash equivalents at end of year                   (31,000)
Supplemental disclosures of non-cash investing and financing activities:                      
Common shares issued to preferred shareholders [3]                   17,659,000  
Common shares related to convertible promissory notes [3]                   47,935,000  
Common shares issued to Data Knights shareholders [3]                   (11,937,000)  
Board of director warrant expense                   $ 1,198,000 [9]
[1] Accumulated effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.
[2] Accumulated effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.
[3] Includes impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial statements.
[4] Includes impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.
[5] Impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.
[6] Impact of errors related to improper valuation of stock compensation expense.
[7] Impact of errors related to improper valuation of stock compensation expense.
[8] Impact of errors related to the identification, classification and valuation of equity-classified warrants.
[9] Impact of errors related to the identification, classification and valuation of equity-classified warrants.
[10] Impact of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the consolidated statements of operations.
[11] Impact of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which are now accounted for under the FVO.
[12] Impact of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously considered, which are now accounted for under the FVO (including accrued interest).
[13] Impact of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously considered, which are now accounted for under the FVO (including accrued interest).
[14] Impact of improper presentation of non-cash interest expense in financing activities.
[15] Includes current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet restatement reconciliation for more information.
[16] Current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet restatement reconciliation for more information.
[17] Current year impact of corrections of errors to the consolidated statements of operations.
[18] Current year impact of corrections of errors to the consolidated statements of operations.